Article, Early Access, 2024

Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort

LIVER INTERNATIONAL, ISSN 1478-3223, 10.1111/liv.15878

Contributors

Tang, Liang-Jie [1] [2] Sun, Dan-Qin 0000-0002-8704-3606 [3] [4] Song, Sherlot Juan [5] Yip, Terry Cheuk-Fung [5] Wong, Grace L-H 0000-0001-5986-4952 [5] Zhu, Pei-Wu [2] Chen, Sui-Dan 0000-0002-5226-8573 [2] Karsdal, Morten [6] Leeming, Diana [6] Jiang, Pei 0000-0001-9060-5158 [7] Wang, Cong [7] Chen, Qiang [1] Byrne, Christopher D. [8] [9] Targher, Giovanni 0000-0002-4325-3900 [10] [11] Eslam, Mohammed [12] [13] [14] [15] George, Jacob [12] [13] [14] [15] Wong, Vincent Wai-Sun 0000-0003-4992-4135 (Corresponding author) [5] Zheng, Ming-Hua 0000-0003-4984-2631 (Corresponding author) [2] [16]

Affiliations

  1. [1] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China
  2. [NORA names: China; Asia, East];
  3. [2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
  4. [NORA names: China; Asia, East];
  5. [3] Jiangnan Univ, Med Ctr, Dept Nephrol, Wuxi, Peoples R China
  6. [NORA names: China; Asia, East];
  7. [4] Nantong Univ, Affiliated Wuxi Clin Coll, Wuxi, Peoples R China
  8. [NORA names: China; Asia, East];
  9. [5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
  10. [NORA names: China; Asia, East];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

N-terminal propeptide of type 3 collagen, chronic kidney disease, liver fibrosis, metabolic dysfunction-associated fatty liver disease, metabolic dysfunction-associated steatotic liver disease, risk prediction

Data Provider: Clarivate